Sarma Duddu, PhD, was named GM and VP of drug delivery technologies for Cima Labs (Brooklyn Park, Minnesota). Most recently, Duddu was VP of pharmaceutical development at Nektar Therapeutics. Cima Labs describes itself as the third-largest drug delivery company in the U.S. It is a subsidiary of Cephalon (Frazer, Pennsylvania).

• MedAire (Tempe, Arizona) reported the addition of new staff and reorganization designed to complement the medical team's specialties. Robb Leigh, MD, has been named chief medical officer, global response services. Leigh is an emergency room physician and practicing doctor in MedAire's 24/7 global response center. Paulo Alves, MD, has been named MedAire VP, aviation and maritime health. Alves was formerly MedAire's corporate medical director. David Streitwieser, MD, has been named MedLink medical director. Streitwieser is medical director of MedAire's 24/7 global response center. MedAire provides an integrated solution of remote medical expertise, education and equipment for travelers in the aviation and maritime industries.

• Neovasc (Vancouver, British Columbia) reported changes to its senior management team. Cynthia Roney has been named VP of sales and marketing. Roney has been with the company since July 2008. In addition, Neovasc named Fabio De Pasquale as director of regulatory affairs. De Pasquale brings over 18 years of industry experience to his new role. Neovasc makes vascular devices.

Edward Currie, MD, was named executive VP of corporate development of SIRS-Lab (Jena, Germany). Currie specializes in clinical microbiology and infectious disease, and most recently was COO of Kuros BioSurgery. SIRS-Lab focuses on sepsis-relevant pathogens and resistances.

Kevin Glennon, RN, was promoted to executive director of clinical services for Total Medical Solutions (TMS; Orlando, Florida). Glennon joined TMS in 1997 and most recently was director of home health. TMS is a provider of home health care and complex care services for the workers' compensation industry.